HPV and Pap Testing Market Opportunity Analysis, 2018-2026

HPV stands for human papillomavirus, which constitutes a group of more than 150 related viruses. Every HPV virus has a number or a type. HPVs are attracted to only a specific cell type known as squamous epithelial cells and the viruses can live only in these cells. Some of the human papillomavirus can cause non-cancerous tumors while others can lead to cancer, which includes cancer of the cervix, vagina, vulva, anus, penis, and parts of mouth and throat that comprises mostly of the moist skin in the body. These types of HPVs are considered to be mucosal, as they invade in the living cells on mucosal surfaces.

Click To Continue Reading on HPV and Pap Testing Market

Diagnosis and treatment of the abnormal cells developing in the cervix help in the prevention of cervical cancer. The two most common tests employed to check the behavior of cervical cells are HPV and Pap tests. The Pap test is a simple smear test, which provides an effective screening measure to determine whether the cervical cells are normal or abnormal. HPV testing is performed to screen for human papillomavirus in the cervix that can lead to cervical cancer. A person observed with abnormal cells through Pap test is recommended to opt for HPV testing for further evaluation of cervical cancer. According to the National Cervical Cancer Coalition 2017, around 12,000 women are diagnosed with cervical cancer per year in the U.S. Moreover, the American Sexual Health Association (ASHA) suggests that cervical cancer is amongst one of the most preventable types of cancer. These cancers can be prevented through early detection and treatment of abnormal cell changes that occurs in the cervix prior to the development of cervical cancer cells.

Request Sample Copy of this Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/1733

Moreover, technological advancements in improving the existing accuracy of HPV testing is also expected to drive growth of global HPV testing and Pap test market. For instance, in April 2014, Roche Molecular Systems received FDA approval for Cobas HPV test as a primary screening test that would facilitate mitigation of late-stage survival cancer. However, the inaccuracy of smear based Pap test leading to low reliability is expected to hamper growth of the global HPV and Pap testing market.

Key Vendors:Qiagen N.V., Abbott Laboratories, Becton, Dickinson & Company, Hologic, Inc., Quest Diagnostics, Femasys, Inc., Roche Diagnostics, Arbor Vita Corporation, Onco Health Corporation, Seegene, Inc., and others.

Ongoing Residential Projects in Mumbai Luring Buyers

According to real estate reports, sales are plummeting in India’s housing market. But this has not stopped developers from introducing new projects in Mumbai as well as Pune. Several ongoing residential projects in these cities are luring buyers to make an investment.

In Mumbai, there has been a significant increase in construction work in ultra-luxury and affordable segments. Sale has gone up for flats below 50 Lacs INR. Even in areas like Mumbai’s metropolitan region and Greater Mumbai, average property rates have increased.

Companies are coming up with new property formats for capitalising on the change in environment caused by proposed real estate laws and changed economic scenario. Not only developers are offering quality properties but buyers are also demanding luxury homes, equipped with modern amenities. In order to lure buyers, developers are building stylish high-rise apartments with world-class facilities.

High-rise buildings have become quite popular among developers as they are constructing such buildings to differentiate their projects from the others. Not just in Mumbai but skyscrapers have also started making a mark on Pune’s skyline. The governing body of the Pune Municipal Corporation in 2011 gave the green signal to increase maximum permissible height of high-rise buildings in Pune to 100 metres from 36 metres.

Many buyers are looking for premium properties in Mumbai and luxury flats in Pune. To cater to this rising demand from wealthy buyers, developers have started building iconic premium properties. High-rise buildings are not only the need of the hour but they also offer stunning views of the city due to which many buyers prefer buying a flat on the top floor of skyscrapers. There are various other advantages associated with living in a high-rise structure. Apart from views, the exclusivity attached to the project also lures buyers. In a city like Mumbai, staying on the top floor of a high-rise building ensures zero noise pollution and clean air.

Such buildings have an iconic status that cannot be replicated easily by other developers. There is a status attached to such constructions which is difficult to find in other project. Many developers are trying to attract buyers by offering world class amenities in such buildings such as a swimming pool and gymnasium. Since such flats have a controlled entrance, security is also ensured.

In last few months, various residential projects priced between 6 Crore INR to 20 Crore INR have been announced by real estate companies in Mumbai. Things have changed to a great extent after Narendra Modi came into power. Foreign investors are getting the stability they were looking for in the Indian economy. The stability factor has helped Foreign Institutional Investors (FIIs) to start investing in the Indian realty sector for attractive returns.

NRIs have also increased their investment in luxury homes in cities like Mumbai, Pune and New Delhi. Many foreign property development companies are also entering the realty market. They are collaborating with Indian property developers to lure home buyers with stylish, super-luxury flats and penthouses.

Chronic Kidney Disease Drugs Market Global Forecast to 2026

Chronic kidney disease (CKD) involves gradual loss of functioning of kidneys. The normal function of kidneys are to filter out and excrete wastes, and excess fluids from the blood are excreted through urine. However, when an individual is suffering from chronic kidney disease, kidneys cannot perform their natural function and wastes, fluids, and electrolytes build up in the body in excess amounts. Signs and symptoms of chronic kidney disease are not apparent until kidney function becomes significantly impaired.

Click To Continue Reading on Chronic Kidney Disease Drugs Market

The global chronic kidney disease drugs market was valued at US$ 12,468.2 million in 2017 and is expected to witness a robust CAGR of 3.1% over the forecast period (2018 – 2026).

The supportive treatment of chronic kidney disease includes delaying the disease progression and kidney damage. Diseases and conditions such as type 1 or type 2 diabetes, high blood pressure, polycystic kidney disease, and recurrent kidney infection leads to chronic kidney disease. Factors that increase risk of chronic kidney disease include diabetes, high blood pressure, smoking, obesity, and others.

Management of the disease involves managing the co-morbidities such as blood pressure, diabetes medications, medications to lower cholesterol levels, and anemia treatment. Kidney dialysis and kidney transplant may become a necessity, as the condition becomes worse. There is no direct medication available for the treatment of chronic kidney disease. Chronic kidney diseases may trigger other healthcare issues such as cardiovascular diseases.